Literature DB >> 7509365

Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.

P J Jose1, D A Griffiths-Johnson, P D Collins, D T Walsh, R Moqbel, N F Totty, O Truong, J J Hsuan, T J Williams.   

Abstract

Eosinophil accumulation is a prominent feature of allergic inflammatory reactions, such as those occurring in the lung of the allergic asthmatic, but the endogenous chemoattractants involved have not been identified. We have investigated this in an established model of allergic inflammation, using in vivo systems both to generate and assay relevant activity. Bronchoalveolar lavage (BAL) fluid was taken from sensitized guinea pigs at intervals after aerosol challenge with ovalbumin. BAL fluid was injected intradermally in unsensitized assay guinea pigs and the accumulation of intravenously injected 111In-eosinophils was measured. Activity was detected at 30 min after allergen challenge, peaking from 3 to 6 h and declining to low levels by 24 h. 3-h BAL fluid was purified using high performance liquid chromatography techniques in conjunction with the skin assay. Microsequencing revealed a novel protein from the C-C branch of the platelet factor 4 superfamily of chemotactic cytokines. The protein, "eotaxin," exhibits homology of 53% with human MCP-1, 44% with guinea pig MCP-1, 31% with human MIP-1 alpha, and 26% with human RANTES. Laser desorption time of flight mass analysis gave four different signals (8.15, 8.38, 8.81, and 9.03 kD), probably reflecting differential O-glycosylation. Eotaxin was highly potent, inducing substantial 111In-eosinophil accumulation at a 1-2 pmol dose in the skin, but did not induce significant 111In-neutrophil accumulation. Eotaxin was a potent stimulator of both guinea pig and human eosinophils in vitro. Human recombinant RANTES, MIP-1 alpha, and MCP-1 were all inactive in inducing 111In-eosinophil accumulation in guinea pig skin; however, evidence was obtained that eotaxin shares a binding site with RANTES on guinea pig eosinophils. This is the first description of a potent eosinophil chemoattractant cytokine generated in vivo and suggests the possibility that similar molecules may be important in the human asthmatic lung.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509365      PMCID: PMC2191401          DOI: 10.1084/jem.179.3.881

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.

Authors:  L H Faccioli; S Nourshargh; R Moqbel; F M Williams; R Sehmi; A B Kay; T J Williams
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness.

Authors:  B L Bradley; M Azzawi; M Jacobson; B Assoufi; J V Collins; A M Irani; L B Schwartz; S R Durham; P K Jeffery; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

3.  Eosinophilic inflammation in asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; G Barnéon; N Ghavanian; I Enander; P Venge; S Ahlstedt; J Simony-Lafontaine; P Godard
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

4.  Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells.

Authors:  Y Jiang; A J Valente; M J Williamson; L Zhang; D T Graves
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

5.  Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.

Authors:  P M e Silva; M A Martins; H C Faria Neto; R S Cordeiro; B B Vargaftig
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

6.  Identification of a second neutrophil-chemoattractant cytokine generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to melanoma-growth-stimulatory activity.

Authors:  P J Jose; P D Collins; J A Perkins; B C Beaubien; N F Totty; M D Waterfield; J Hsuan; T J Williams
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

Review 7.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

8.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.

Authors:  W C Darbonne; G C Rice; M A Mohler; T Apple; C A Hébert; A J Valente; J B Baker
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Validation of a non-invasive technique to assess development of airway hyperreactivity in an animal model of immunologic pulmonary hypersensitivity.

Authors:  D A Griffiths-Johnson; M H Karol
Journal:  Toxicology       Date:  1991-01       Impact factor: 4.221

10.  Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family.

Authors:  J Van Damme; P Proost; J P Lenaerts; G Opdenakker
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  176 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Eotaxin and asthma: some answers, more questions.

Authors:  C J Corrigan
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 3.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

4.  Eosinophilic venulitis in the small intestines in a mouse model of late asthma.

Authors:  Linh Kan Bui; Toshiharu Hayashi; Tomomi Nakashima; Yoichiro Horii
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

5.  Chemokines in the limbal form of vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

6.  Eotaxin expression in Sephadex-induced lung injury in rats.

Authors:  R F Guo; P A Ward; J A Jordan; M Huber-Lang; R L Warner; M M Shi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 7.  The attraction of chemokines as a target for specific anti-inflammatory therapy.

Authors:  James E Pease; Timothy J Williams
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

8.  Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin.

Authors:  M M Teixeira; T N Wells; N W Lukacs; A E Proudfoot; S L Kunkel; T J Williams; P G Hellewell
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 9.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 10.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.